Posted inMarket
Canaccord Reaffirms Zscaler Stock Rating Amid Sales Force Transition
Canaccord Genuity maintains its current investment rating for Zscaler as the cloud security firm navigates a major sales force reorganization.
Posted inMarket
H.C. Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals Following Regulatory Nod in China
H.C. Wainwright maintains its Buy rating for Milestone Pharmaceuticals following a significant regulatory approval in China.
Posted inMarket
BMO Lowers Tyson Stock Price Target Following Guidance Revision
BMO adjusts its price target for Tyson shares down to $65 after the company lowers its financial guidance, reflecting ongoing market challenges.
Posted inMarket
Bernstein Reaffirms Outperform Rating on IREN Stock With $100 Price Target
Investment firm Bernstein maintains its Outperform rating on IREN stock, setting an ambitious price target of $100 amid evolving market dynamics.
